MedTrace Logo

Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery

NCT04899492 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-11-07

No results posted yet for this study

Summary

This trial offers support and assistance to patients wishing to quit smoking in order to increase the success rate of smoking cessation and all the benefits associated with it. Patients will be monitored by a tobacco specialist and will be able to benefit from one or more therapies complementary to Nicotine Replacement Therapy (NRT): Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy.

Conditions

Interventions

BEHAVIORAL

Motivational Interviewing (MI)

1 to 3 Motivational Interviewing (MI) should be performed after randomization by a psychotherapist

BEHAVIORAL

Cognitive Behavioural Therapy (CBT)

6 Cognitive Behavioural Therapy (CBT) sessions should be performed after motivational interviewing up to 6 months by a psychotherapist

BEHAVIORAL

Hypnotherapy

About 3 Hypnotherapy sessions should be performed after motivational interviewing up to 6 months by a hypnotherapist

DRUG

Nicotine Replacement Therapy (NRT)

All patients will receive Nicotine Replacement Therapy (NRT) from randomization up to 6 months

Sponsors & Collaborators

  • National Cancer Institute, France

    collaborator OTHER_GOV

  • Institut Cancerologie de l'Ouest

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2024-03-29
Completion
2024-03-29

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899492 on ClinicalTrials.gov